WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008097525) LOCAL COMPLEMENT INHIBITION FOR TREATMENT OF COMPLEMENT-MEDIATED DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/097525    International Application No.:    PCT/US2008/001483
Publication Date: 14.08.2008 International Filing Date: 05.02.2008
IPC:
A61K 39/395 (2006.01), A61P 19/02 (2006.01), A61P 11/06 (2006.01), A61P 11/00 (2006.01), A61P 25/28 (2006.01), A61P 25/16 (2006.01)
Applicants: POTENTIA PHARMACEUTICALS, INC. [US/US]; 201 E. Jefferson Street, Suite 312, Louisville, KY 40202 (US) (For All Designated States Except US).
FRANCOIS, Cedric [BE/US]; (US) (For US Only).
DESCHATELETS, Pascal [CA/US]; (US) (For US Only).
OLSON, Paul [US/US]; (US) (For US Only)
Inventors: FRANCOIS, Cedric; (US).
DESCHATELETS, Pascal; (US).
OLSON, Paul; (US)
Agent: BAKER, Hunter, C.; Choate, Hall & Stewart LLP, Two International Place, Boston, MA 02110 (US)
Priority Data:
60/899,474 05.02.2007 US
Title (EN) LOCAL COMPLEMENT INHIBITION FOR TREATMENT OF COMPLEMENT-MEDIATED DISORDERS
(FR) INHIBITION LOCALE DE COMPLÉMENT DESTINÉE AU TRAITEMENT DE TROUBLES INDUITS PAR LE COMPLÉMENT
Abstract: front page image
(EN)The present invention features the local administration of complement inhibitors for treatment of complement-mediated disorders. In certain embodiments the invention features inhibiting activation of one or more locally produced complement proteins. The invention provides sustained release formulations and devices comprising a complement inhibitor and methods of use thereof.
(FR)La présente invention concerne l'administration locale d'inhibiteurs de complément dans le traitement de troubles induits par le complément. Dans certains modes de réalisation, la présente invention concerne l'inhibition de l'activation d'une ou de plusieurs protéines de complément produites localement. L'invention concerne également des formulations à libération prolongée et des dispositifs comprenant un inhibiteur de complément, ainsi que des procédés d'utilisation de ceux-ci.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)